New digital coaching aims to keep heart failure patients out of hospital

NCT ID NCT07580508

Not yet recruiting Disease control Sponsor: Universiti Putra Malaysia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests a four-month digital program designed to help people with chronic heart failure take their medications as prescribed. The program includes personalized planning, motivational counseling, and symptom tracking. Researchers will enroll 870 adults in Pakistan who have trouble sticking to their heart failure medicines, and measure whether the program improves medication adherence and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: digital behavioural intervention (autonomy-competence program)
What this could lead to: If successful, this could provide a low-cost, scalable way to help heart failure patients stick to their medications, potentially reducing hospital stays and improving daily life.
What could go wrong: This is an early-stage trial in a single country (Pakistan), so results may not apply elsewhere. The intervention is behavioural, not a drug, so its effects may be modest and depend on patient engagement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE (CHF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congestive heart failure heart failure Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC HEART FAILURE (CHF) HEART FAILURE

Contacts and locations

Locations

Civil Hospital Karachi, Dr. Ruth K. M. Pfau Civil Hospital Karachi

Karachi, 74600, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.